ArticleEJNMMI research2018

The tetraamine chelator outperforms HYNIC in a new technetium-99m-labelled somatostatin receptor 2 antagonist.

Keelara Abiraj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.